Ropinirole sustained release tablets 8mg “KMP”, manufactured by Kyoso Mirai Pharma, contain Ropinirole Hydrochloride. This extended-release medication, with YJ code 1169013G2061 and a standard of 8mg per tablet, is used for the treatment of Parkinson’s disease.
Ropinirole sustained release tablets 8mg “KMP”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
